Merus N.V.·4

Feb 19, 5:00 PM ET

Sirulnik Andres 4

4 · Merus N.V. · Filed Feb 19, 2020

Insider Transaction Report

Form 4
Period: 2020-02-14
Sirulnik Andres
EVP & Chief Medical Officer
Transactions
  • Award

    Share Option (right to buy)

    2020-02-14+57,50057,500 total
    Exercise: $18.61Exp: 2030-02-14Common Shares (57,500 underlying)
Footnotes (1)
  • [F1]Options vest over a four-year period from January 1, 2020. 25% vest on January 1, 2021 and in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION